Equilis® Te, Suspension for injection for horses
Equilis Te is a suspension for injection containing purified Tetanus Toxoid with Matrix-CTM adjuvant technology to provide active immunity against tetanus.
Presentation
Clear opalescent suspension for injection
Active ingredients
Each 1 ml dose contains:
Tetanus toxoid: 40 Lf1
1 Flocculation equivalents; corresponds with ≥ 30 IU/ml guinea pig serum in the Ph. Eur. potency test.
Target species
Horses
Indications for use
Active immunisation of horses from 6 months of age against tetanus to prevent mortality.
Onset of immunity: 2 weeks after the primary vaccination course.
Duration of immunity: 17 months after the primary vaccination course, 2 years after the first revaccination.
Withdrawal periods
Zero days
Packaging
Cardboard box with 10 glass vials of 1 ml (1 dose).
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: September 2024